Delivery Order SPE2DB22D3016-SPE2DB24FAVU7

Award Date 5/15/24
Potential Completion Date 5/16/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,656.50, is for the delivery of Amlodipine-Valsartan 10-160 mg tablets in quantities of 30 per bottle. This is a firm fixed-price delivery order contract with a performance period through July 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,437.87, is for the delivery of Amlodipine-Valsartan 10-320 mg tablets. This is a firm fixed-price delivery order contract with a completion date of February 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,745.76, is for the delivery of AMLODIPINE-VALSARTAN 10-320 mg 30-count tablets. This is a firm fixed price delivery order contract with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of 4,565,964,777 units of the pharmaceutical product Amlodipine-Valsartan 10-160 mg, with a ceiling value of $1,270.76. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 30, 2024. The contract does not have a set-aside designation. As a large...
This federal contract award is for the delivery of pharmaceutical products, specifically Amlodipine-Valsartan 5-160 mg 30s, to the Defense Logistics Agency (DLA) on a firm-fixed-price basis. The contract has an ultimate completion date of April 23, 2024 and a ceiling value of $3,334.82. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and the Department...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,770.57 firm-fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract does not have a set-aside designation and has a completion date of June 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,888.55 Delivery Order contract is for the supply of AMLODIPINE-VALSARTAN 5-160 MG 30S, a cardiovascular medication, and has a period of performance through November 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,058.54 firm-fixed-price delivery order is for the supply of valsartan-HCTZ 80-12.5 mg tablets, with an ultimate completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,849.84, is a delivery order for the supply of AMLODIPINE-VALSARTAN 5-320 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.86, is for the delivery of 4567330158 AMLODIPINE-VALSARTAN 5-160 MG 30S, a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order with a performance period running through February 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAVU7
    Delivery Order

This federal contract award, with the ID SPE2DB22D3016|SPE2DB24FAVU7, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp's Corporate Office Division. The $2,538.76 firm fixed-price delivery order is for the supply of Amlodipine-Valsartan 5-160 mg tablets, with a completion date of May 16, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award was made on a full and open competition basis without any set-aside designation.

Generated 8/23/24, 4:34 PM